Lauren Demayo Trainor

Lauren DeMayo Trainor is a seasoned finance professional currently serving as Senior Director and Head of Finance at Thymmune Therapeutics since December 2024. Prior to this role, Lauren contributed to bluebird bio from February 2019 to December 2024, where responsibilities included project management for quarterly closes, technical accounting, and leading the company through a Form 10-K restatement. Additionally, Lauren held the position of Director of FP&A at 2seventy bio, a spin-off of bluebird bio, where efforts focused on aligning financial planning with business objectives and managing annual budgets in a constrained financial environment. Earlier experience includes leadership roles in Accounting Operations that achieved significant improvements in GL close times. Lauren also served as a Board Member for NOAH - Neighborhood of Affordable Housing from February 2013 to December 2021. Academic qualifications include a Master of Science in Accounting from the D'Amore-McKim School of Business at Northeastern University.